Table 2. Clinical characteristics of individual CBP patients.
Patient ID | Age (years) | Sex | WBC | Diagnosis |
---|---|---|---|---|
1 | 47 | Female | 3.4 | CBP (severe) |
2 | 50 | Female | 3.3 | CBP (mild) |
3 | 37 | Female | 3.7 | CBP (mild) |
4 | 47 | Male | 3.3 | CBP (mild) |
5 | 45 | Female | 3.3 | CBP (mild) |
6 | 43 | Male | 2.7 | CBP (mild) |
7 | 35 | Male | 2.3 | CBP (mild) |
8 | 38 | Female | 3.3 | CBP (mild) |
9 | 47 | Female | 3.7 | CBP (mild) |
10 | 37 | Male | 3.8 | CBP (severe) |
11 | 35 | Female | 2.7 | CBP (mild) |
12 | 43 | Female | 3.5 | CBP (mild) |
13 | 40 | Female | 2.8 | CBP (mild) |
14 | 39 | Female | 3.3 | CBP (mild) |
15 | 41 | Female | 3.8 | CBP (mild) |
16 | 51 | Female | 3.5 | CBP (severe) |
17 | 28 | Male | 3.7 | CBP (mild) |
18 | 26 | Female | 3.3 | CBP (severe) |
19 | 50 | Female | 3.2 | CBP (severe) |
20 | 36 | Female | 2.8 | CBP (mild) |
21 | 44 | Female | 3.1 | CBP (mild) |
22 | 35 | Female | 3.2 | CBP (severe) |
23 | 42 | Female | 3.2 | CBP (mild) |
24 | 32 | Male | 2.8 | CBP (mild) |
25 | 41 | Male | 2.9 | CBP (mild) |
26 | 40 | Male | 3.5 | CBP (mild) |
27 | 44 | Female | 3.0 | CBP (mild) |
28 | 39 | Female | 3.0 | CBP (mild) |
29 | 30 | Male | 3.3 | CBP (mild) |
30 | 46 | Female | 3.0 | CBP (mild) |
31 | 41 | Female | 3.2 | CBP (mild) |
32 | 45 | Female | 3.4 | CBP (mild) |
33 | 36 | Female | 3.8 | CBP (mild) |
34 | 27 | Male | 3.9 | CBP (severe) |
35 | 49 | Female | 3.0 | CBP (mild) |
36 | 46 | Female | 2.9 | CBP (mild) |
37 | 43 | Female | 2.9 | CBP (mild) |
38 | 38 | Male | 3.7 | CBP (severe) |
39 | 52 | Female | 3.1 | CBP (mild) |
40 | 46 | Female | 3.8 | CBP (mild) |
41 | 35 | Male | 3.3 | CBP (mild) |
42 | 29 | Female | 2.2 | CBP (mild) |
43 | 38 | Female | 3.3 | CBP (severe) |
44 | 41 | Female | 3.2 | CBP (mild) |
CBP, chronic benzene poisoning; WBC, white blood cell.